142 related articles for article (PubMed ID: 12845235)
21. [A meta-analysis of the effects of direct hemoperfusion with polymyxin B-immobilized fiber on prognosis in severe sepsis].
Qiu XH; Liu SQ; Guo FM; Yang Y; Qiu HB
Zhonghua Nei Ke Za Zhi; 2011 Apr; 50(4):316-21. PubMed ID: 21600152
[TBL] [Abstract][Full Text] [Related]
22. Changes in plasma erythropoietin and interleukin-6 concentrations in patients with septic shock after hemoperfusion with polymyxin B-immobilized fiber.
Nakamura T; Ebihara I; Shimada N; Koide H
Intensive Care Med; 1998 Dec; 24(12):1272-6. PubMed ID: 9885879
[TBL] [Abstract][Full Text] [Related]
23. Effect of polymyxin B-immobilized fiber hemoperfusion on serum high mobility group box-1 protein levels and oxidative stress in patients with acute respiratory distress syndrome.
Nakamura T; Fujiwara N; Sato E; Kawagoe Y; Ueda Y; Yamada S; Koide H
ASAIO J; 2009; 55(4):395-9. PubMed ID: 19506468
[TBL] [Abstract][Full Text] [Related]
24. Removal of increased circulating CD4+CD25+Foxp3+ regulatory T cells in patients with septic shock using hemoperfusion with polymyxin B-immobilized fibers.
Ono S; Kimura A; Hiraki S; Takahata R; Tsujimoto H; Kinoshita M; Miyazaki H; Yamamoto J; Hase K; Saitoh D
Surgery; 2013 Feb; 153(2):262-71. PubMed ID: 22884251
[TBL] [Abstract][Full Text] [Related]
25. Effect of hemoperfusion with polymyxin B-immobilized fiber on plasma endothelin-1 and endothelin-1 mRNA in monocytes from patients with sepsis.
Ebihara I; Nakamura T; Shimada N; Shoji H; Koide H
Am J Kidney Dis; 1998 Dec; 32(6):953-61. PubMed ID: 9856510
[TBL] [Abstract][Full Text] [Related]
26. Clinical Effects of a Longer Duration of Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion Therapy for Severe Sepsis and Septic Shock.
Yamashita C; Hara Y; Kuriyama N; Nakamura T; Nishida O
Ther Apher Dial; 2015 Aug; 19(4):316-23. PubMed ID: 26386218
[TBL] [Abstract][Full Text] [Related]
27. Removal of cytokine inducing substances by polymyxin-B immobilized polystyrene-derivative fibers during in vitro hemoperfusion of 10% human plasma containing Staphylococcus aureus challenge.
Jaber BL; Barrett TW; Cendoroglo Neto M; Sundaram S; King AJ; Pereira BJ
ASAIO J; 1998; 44(1):48-53. PubMed ID: 9466501
[TBL] [Abstract][Full Text] [Related]
28. Effects of endotoxin absorber hemoperfusion on microcirculation in septic pigs.
Yeh YC; Yu LC; Wu CY; Cheng YJ; Lee CT; Sun WZ; Tsai JC; Lin TY;
J Surg Res; 2017 May; 211():242-250. PubMed ID: 28501124
[TBL] [Abstract][Full Text] [Related]
29. Treatment with polymyxin B-immobilized fiber reduces platelet activation in septic shock patients: decrease in plasma levels of soluble P-selectin, platelet factor 4 and beta-thromboglobulin.
Nakamura T; Ebihara I; Shoji H; Ushiyama C; Suzuki S; Koide H
Inflamm Res; 1999 Apr; 48(4):171-5. PubMed ID: 10344466
[TBL] [Abstract][Full Text] [Related]
30. Effects of hemoperfusion with polymyxin B-immobilized fibre on serum neopterin and soluble interleukin-2 receptor concentrations in patients with septic shock.
Nakamura T; Ebihara I; Shimada N; Suzuki S; Ushiyama C; Shoji H; Koide H
J Infect; 1998 Nov; 37(3):241-7. PubMed ID: 9892527
[TBL] [Abstract][Full Text] [Related]
31. Polymyxin B-immobilized fiber hemoperfusion with low priming volume in an elderly septic shock patient with marked endotoxemia.
Nakamura T; Kawagoe Y; Ueda Y; Koide H
ASAIO J; 2005; 51(4):482-4. PubMed ID: 16156319
[TBL] [Abstract][Full Text] [Related]
32. [Clinical experiences of endotoxin removal columns in septic shock due to urosepsis: report of three cases].
Yuasa J; Naya Y; Tanaka M; Amakasu M; Yamaguchi K
Hinyokika Kiyo; 2000 Nov; 46(11):819-22. PubMed ID: 11193305
[TBL] [Abstract][Full Text] [Related]
33. Effects of polymyxin B immobilized fiber on urinary N-acetyl-beta-glucosaminidase in patients with severe sepsis.
Nakamura T; Kawagoe Y; Matsuda T; Ueda Y; Koide H
ASAIO J; 2004; 50(6):563-7. PubMed ID: 15672789
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review.
Cruz DN; Perazella MA; Bellomo R; de Cal M; Polanco N; Corradi V; Lentini P; Nalesso F; Ueno T; Ranieri VM; Ronco C
Crit Care; 2007; 11(2):R47. PubMed ID: 17448226
[TBL] [Abstract][Full Text] [Related]
35. Selection of hemoperfusion therapy for patients with septic shock on the basis of the primary disease.
Kanno Y; Nemoto H; Nakamoto H; Okada H; Sugahara S; Nishidome K; Yamashita Y; Suzuki H
J Artif Organs; 2003; 6(3):205-10. PubMed ID: 14598105
[TBL] [Abstract][Full Text] [Related]
36. Relationship between effect of polymyxin B-immobilized fiber and high-mobility group box-1 protein in septic shock patients.
Sakamoto Y; Mashiko K; Matsumoto H; Hara Y; Kutsukata N; Yamamoto Y
ASAIO J; 2007; 53(3):324-8. PubMed ID: 17515723
[TBL] [Abstract][Full Text] [Related]
37. Modulation of human leukocyte antigen-DR on monocytes and CD16 on granulocytes in patients with septic shock using hemoperfusion with polymyxin B-immobilized fiber.
Ono S; Tsujimoto H; Matsumoto A; Ikuta S; Kinoshita M; Mochizuki H
Am J Surg; 2004 Aug; 188(2):150-6. PubMed ID: 15249240
[TBL] [Abstract][Full Text] [Related]
38. Exacerbation of prothrombin time-international normalized ratio before second polymyxin B cartridge hemoperfusion predicts poor outcome of patients with severe sepsis and/or septic shock.
Ishizuka M; Terasaki A; Kubota K
J Surg Res; 2016 Jan; 200(1):308-14. PubMed ID: 26319975
[TBL] [Abstract][Full Text] [Related]
39. Hemoperfusion with polymyxin B-immobilized fibers reduced the number of CD16+ CD14+ monocytes in patients with septic shock.
Tsujimoto H; Ono S; Hiraki S; Majima T; Kawarabayashi N; Sugasawa H; Kinoshita M; Hiraide H; Mochizuki H
J Endotoxin Res; 2004; 10(4):229-37. PubMed ID: 15373966
[TBL] [Abstract][Full Text] [Related]
40. Polymyxin b-immobilized fiber reduces increased plasma endothelin-1 concentrations in hemodialysis patients with sepsis.
Nakamura T; Ushiyama C; Suzuki S; Shoji H; Shimada N; Ebihara I; Koide H
Ren Fail; 2000 Mar; 22(2):225-34. PubMed ID: 10803767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
